Sara Imboden
Papers
4
Total Citations
167
H-Index
3
About
Dr. Sara Imboden is a leading gynecologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for the treatment of endometrial and cervical cancers. Her most impactful contributions lie in the refinement of sentinel lymph node (SLN) mapping and fertility-sparing procedures. Her landmark 2016 study on laparoscopic indocyanine green (ICG) SLN mapping in endometrial cancer (87 citations) established a critical, reproducible alternative to robotic approaches, demonstrating high detection rates and low false-negative rates to reduce surgical morbidity. She is also a pioneer in fertility-preserving oncology, evidenced by her highly cited 2012 work on robot-assisted laparoscopic fertility-sparing radical trachelectomy (74 citations), which helped standardize this complex procedure for young patients. Dr. Imboden continues to shape the field through her leadership in the SLYMEC II study, investigating the prognostic impact of lymphovascular space invasion (LVSI) in early-stage endometrial cancer, and by evaluating next-generation platforms like the Dexter robotic system for on-demand, hybrid hysterectomies. Her work consistently bridges the gap between oncologic radicality and functional preservation, making her a pivotal figure in modern gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4